Bristol-Myers Squibb Gets FDA Approval for Hodgkin’s Lymphoma Treatment

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Large Cap Stocks with Highest Dividends.

Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Bristol-Myers Squibb Company (NYSE:BMY) announced connected March 20 that the U.S. Food and Drug Administration had approved the company’s operation attraction for adults and adolescents aged 12 and older ‌with antecedently untreated signifier III oregon IV classical Hodgkin’s lymphoma. The antitumor therapy, called Opdivo, had antecedently received the greenish airy to dainty assorted precocious oregon metastatic cancers, including ​melanoma, non-small compartment lung cancer, and kidney cancer.

The regulatory authority’s determination is based connected a late-stage survey of 994 patients, which demonstrated that the ‌treatment importantly improved progression-free endurance compared with brentuximab vedotin.

Hodgkin’s lymphoma, besides known arsenic Hodgkin’s disease, is the astir communal signifier of crab successful patients aged 15 to 19. It starts successful achromatic humor cells, which are portion of the body’s immune system, a crab that starts successful achromatic humor cells.

Monica Shaw, MD, Senior Vice President of Oncology Commercialization astatine Bristol-Myers Squibb Company (NYSE:BMY), stated:

“These approvals correspond a defining infinitesimal for radical surviving with classical Hodgkin Lymphoma. In the U.S., we are peculiarly arrogant that Opdivo in operation with AVD present stands arsenic an immunotherapy operation disposable for adults and pediatric patients, ages 12 and older, with antecedently untreated precocious disease. Concurrently, successful the EU, Opdivo in operation with brentuximab vedotin has besides achieved a milestone arsenic the archetypal immunotherapy operation for definite relapsed oregon refractory patients. These milestones bespeak our continued committedness to advancing subject that meaningfully improves the lives of patients and families worldwide.”

While we admit the imaginable of BMY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Oil Stocks with Highest Dividends and 14 Best Energy Stocks to Buy According to Wall Street Analysts

Disclosure: None. Follow Insider Monkey connected Google News.